NCT00973050View on ClinicalTrials.gov

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

Bicalutamide

50 mg Tablet

DRUG

Casodex®

50 mg Tabelt

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00973050 - Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter